Overview

Update
IPO / Stock
Went Public on Aug 20, 2004 / NASDAQ:STXS
Total Equity Funding
$46M in 3 Rounds from 6 Investors
Headquarters:
St Louis, MO
Description:
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.
Founders:
Categories:
Medical Device, Health Care, Biotechnology, Navigation
Website:
http://www.stereotaxis.com
Social:

Company Details

Update

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.

Funding Rounds (4) - $70M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2016$24M / Post Ipo Equity0
May, 2012$10M / Series A0
Jan, 2004$16M / Venture0
Jan, 2003$20M / Venture6

Current Team (3)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    4320 Forest Park Avenue

    Suite 100

    St Louis, MO 63108

    USA

Past Team (6)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos